All In MedTech

FDA Clearance Tracker · P180025-S012

MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth Locator

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 7, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P180025-S012
Device name
MANTA Vascular Closure Device, 14F, MANTA Vascular Closure Device, 18F, MANTA 8F Depth Locator, MANTA 14F Depth Locator
Applicant location
Morrisville, NC
Received
Apr 5, 2024
Decided
Jun 7, 2024
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P180025

Device type

Device class
Class III
Specialty
Cardiology

Every decision under product code MGB

FDA's approval statement

As written in FDA's record.

Approval for the following manufacturing sites:Vascular Solutions LLC6464 Sycamore Court NorthMinneapolis, MN 55369Teleflex LLC North American Distribution Center (NADC)11245 N. Distribution CoveOlive Branch, MS 38654

Source documents

Other decisions for Teleflex Medical, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

3 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.